Market News
Global Microcatheter Market- Recent Developments
Product Launch and Approvals
- On November 30, 2023, Transit Scientific, a U.S.-based medical device company specializing in innovative solutions for vascular procedures, announced the FDA clearance of its microcatheter designed for the precise delivery of a broad range of embolic agents. This milestone marks a significant advancement in microcatheter technology, offering clinicians a differentiating new tool to enhance patient care.
- On March 20, 2023, Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, announced the launch of its SwiftNINJA Steerable Microcatheter product line. New sizes include a low-profile 2.4F distal diameter option in 125-cm and new longer 150-cm lengths.
- In April 2022, Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use. The platform is indicated to guide and support a guidewire during access of the peripheral or coronary vasculature, allow for wire exchanges, and provide a conduit for delivery of saline solutions or diagnostic contrast agents.
Business Development Activities by the Market Players
- On November 1, 2023, Embolx Inc., a leading provider of minimally invasive medical devices, announced its international distribution partnership with Girlow USA, a renowned global distributor of advanced medical equipment. This collaboration aims to expand availability beyond the U.S. and Europe and improve global access to Embolx's groundbreaking medical technologies, which includes Sniper Balloon Occlusion Microcatheter.
- On January 4, 2023, Verana Health, a digital health company elevating quality in real-world data, and Sight Sciences, Inc., an eye care technology company focused on creating innovative solutions intended to transform care and improve patients' lives, announced a research collaboration designed to provide insights that may lead to improved outcomes for patients with primary open-angle glaucoma (POAG) by using OMNI Surgical System, indicated for canaloplasty (the microcatheterization and viscodilation of Schlemm's canal).